| Literature DB >> 28279421 |
Michelle N Johnson1, Richard Steingart2, Joseph Carver3.
Abstract
Management of cardiovascular disease in patients with cancer and cancer survivors requires particular clinical expertise and skills that are central to cardio-oncology. The areas of knowledge required include specific cardiovascular complications directly related to oncologic therapies and the impact of cancer and its therapies on existing or potential cardiovascular comorbidities. Many cancer therapeutics have potential cardiotoxicity. The conversion of many cancers to chronic conditions, rather than fatal diseases, has produced a population of patients with cancer at high risk for cardiovascular diseases that require specialized knowledge of treating physicians. Thus, there is a compelling need for enhanced cardio-oncology training.Entities:
Keywords: Cancer therapeutics; Cardio-oncology; Cardiovascular disease; Fellowship
Mesh:
Year: 2017 PMID: 28279421 DOI: 10.1016/j.hfc.2016.12.012
Source DB: PubMed Journal: Heart Fail Clin ISSN: 1551-7136 Impact factor: 3.179